Edition:
United States

Impax Laboratories Inc (IPXL.OQ)

IPXL.OQ on NASDAQ Stock Exchange Global Select Market

17.25USD
12:15pm EST
Change (% chg)

$-1.40 (-7.51%)
Prev Close
$18.65
Open
$18.20
Day's High
$18.20
Day's Low
$16.65
Volume
216,194
Avg. Vol
336,647
52-wk High
$25.70
52-wk Low
$7.80

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Burr

66 Independent Chairman of the Board

Paul Bisaro

56 2017 President, Chief Executive Officer, Director

Bryan Reasons

49 2012 Chief Financial Officer, Senior Vice President - Finance

Douglas Boothe

53 2016 President - Generics Division

Michael Nestor

64 2008 President - Impax Specialty Pharmaceutical Division